Abilify Dosage and Administration

Links shared publicly online about this topic

U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated With Autistic Disorder In Patients

medicalnewstoday.com — “(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug ApplView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 28, 2009 at 11:28 am By:

mnt_clinical MNT Clinical Trials Health News

U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated.. http://bit.ly/51H21G

2 years ago...

U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)

drugs.com — “Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 24, 2009 at 12:10 am By:

drugscom Drugs.com Health Site

FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P

2 years ago...

Abilify And Teens (Newest posts first) - The People's Medicine Community

prescriptiondrug-info.com — “My 13 yr old son has just been prescribed Abilify and I need to know if anyone has experience with their teen being on this My 13 year old son was recently prescribed Abilify by a psychiatrist who spend a grand total of 15 minutes speaking with him When I expressed my concern about this medication t (Newest posts first)View full resource at prescriptiondrug-info.com

  • View Related
  • Share

Most Recently Shared on January 3, 2011 at 6:35 am By:

druginfo Medicine Community Support

" My 13 year old son was recently prescribed Abilify by a psychiatrist who spend a grand total of 15 minutes s http://PD0.US/F180739

1 year ago...

Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com

everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 3:09 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar

2 years ago...

FDA approves sNDA for pediatric autism drug ABILIFY

news-medical.net — “Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 21, 2009 at 9:29 am By:

Obesity_News News-Medical.Net Health News

Obesity News: FDA approves sNDA for pediatric autism drug ABILIFY: Bristol-Myers Squibb Company an.. http://twurl.nl/kl8lfe

3 years ago...

ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate - Business Wire - Wire - BradentonHerald.com

bradenton.com — “Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. , announced today that the U.S. Food and Drug Administration (FDA) has approved ABILIFY ® (aripiprazole) as an adjunct to the mood stabilizers lithium or valproate for the maintenance treatment of Bipolar I Disorder.View full resource at bradenton.com

  • View Related
  • Share

Most Recently Shared on February 17, 2011 at 5:02 pm By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I ... http://bit.ly/fnyJ5i #bipolar

1 year ago...

FDA Approves New Dosage Strength for Intelence

drugs.com — “Intelence (etravirine) is used to treat HIV infection. Includes Intelence side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 4, 2011 at 4:10 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves New Dosage Strength for Intelence: TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S. Fo... http://bit.ly/fCWTaJ #drug

1 year ago...

FDA Recommends Lower Dosage for Painkiller Acetaminophen - TIME

time.com — “An FDA advisory panel has recommended that the maximum over-the-counter dose of the popular pain reliever acetaminophen, known as Tylenol, be loweredView full resource at time.com

  • View Related
  • Share

Most Recently Shared on July 1, 2009 at 2:41 pm By:

CDC H1N1 Flu | Monovalent Influenza Vaccine Dosage, Administration, and Storage

cdc.gov — “CDC H1N1 Flu | Monovalent Influenza Vaccine Dosage, Administration, and StorageView full resource at cdc.gov

  • View Related
  • Share

Most Recently Shared on November 4, 2009 at 12:53 am By:

Health_Feed Health Feed Health News

#HEALTH 2009 H1N1 Vaccine Dosage, Administration, and Storage http://ow.ly/15ZfBD

3 years ago...

FDA Approves New Dosage Strength For INTELENCE(R)

medicalnewstoday.com — “The U.S. Food and Drug Administration(FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicateView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 4, 2011 at 5:05 pm By:

Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths

drugs.com — “Simcor (niacin ER and simvastatin) is used for Hyperlipidemia. Information from Drugs.com includes Simcor side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on July 30, 2010 at 1:29 am By:

drugscom Drugs.com Health Site

Abbott's Simcor (niacin extended-release/simvastatin) Receives FDA Approval for New Dosage Strengths - http://bit.ly/aBBY2A

2 years ago...

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin Extended-release/simvastatin)

medicalnewstoday.com — “Abbott has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. simcor is a fiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 12, 2009 at 12:22 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR® (niacin: http://bit.ly/8fMHnz Full http://bit.ly/78Vmva

2 years ago...

Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended-release/simvastatin)

medicalnewstoday.com — “Abbott (nyse: abt) has submitted a supplemental new drug application (snda) to the u.s. food and drug administration (fda) for two new dosage strengths of simcor®, a cholesterol medication. sView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 11, 2009 at 3:19 pm By:

HeartsHealth Heart Health Health News

MedicalNewsToday: Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin: http://bit.ly/4HlCmF Full http://bit.ly/7vMN53

2 years ago...

Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency

medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 16, 2011 at 7:05 am By:

mnt_cysticfibro MNT Cystic Fibrosis Health News

Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN

11 months ago...

U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine

medicalnewstoday.com — “Edgemont Pharmaceuticals, LLC, a neuroscience focused company, announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.View full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 13, 2011 at 9:05 am By:

mnt_drugapprov MNT Drug Approvals Health News

U.S. FDA Approves New 60 Mg Dosage Strength Of Fluoxetine http://t.co/d38EVTiD #regulatory

7 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • mnt_clinical

    MNT Clinical Trials

    The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.

    View Profile

  • drugscom

    Drugs.com

    Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.

    View Profile

  • druginfo

    Medicine Community

    Highlights from The People's Medicine Community. Share your drug related questions and stories anonymously in our free community. No registration required.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390